# Turning Regional Strengths into Global Impact: The Growth of LATAM Clinical Trials

Page: https://stenobird.com/podcast/moving-medicine-forward-6832193/turning-regional-strengths-into-global-impact-the-growth-of-latam-clinical-trials
Text version: https://stenobird.com/podcast/moving-medicine-forward-6832193/turning-regional-strengths-into-global-impact-the-growth-of-latam-clinical-trials.md
Podcast: [Moving Medicine Forward](https://stenobird.com/podcast/moving-medicine-forward-6832193)
Published: 2026-02-05T20:39:46+00:00
Episode link: https://podcasters.spotify.com/pod/show/moving-medicine-forward/episodes/Turning-Regional-Strengths-into-Global-Impact-The-Growth-of-LATAM-Clinical-Trials-e3emo0d
Audio file: https://anchor.fm/s/eb715a20/podcast/play/115088845/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-1-5%2Ff8996847-7096-15f7-092d-8ab8e3e48925.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/moving-medicine-forward-6832193/episodes/turning-regional-strengths-into-global-impact-the-growth-of-latam-clinical-trials
Duration seconds: 1780

## Resource

In this episode of Moving Medicine Forward, we speak with CTI Founder & CEO Tim Schroeder and Managing Director of Latin America Jaqueline Aguiar about the region’s scientific strength, evolving regulatory landscape, exceptional patient retention, and growing role in rare disease and advanced therapies. They share real‑world examples of record‑speed approvals, high‑quality data, and the cultural dynamics that make LATAM a uniquely powerful environment for clinical trials. A must‑listen for anyone involved in global development or curious about the future of research in emerging markets. 01:22 Why LATAM is a strategic hub: scientific capability, cost efficiency, patient diversity, centralized healthcare, and increasingly fast regulatory timelines. 03:32 Tim on LATAM’s standout strengths — exceptional data quality, major specialty centers, and cost‑effective trial execution. 05:15 CTI’s expansion in the region: driven by rare disease needs, global sponsor demand, and Jaclyn’s leadership building a resilient LATAM infrastructure. 08:04 How LATAM supported global studies during COVID‑19and the ongoing complexities of logistics, sample transport, and country‑specific operations. 10:11 Significant regulatory acceleration across Brazil, Mexico, Colombia, Peru, and Chile — including <60‑day approvals forcomplex studies. 14:20 The role of CTI’s passionate teams and strong site relationships; unique investigator engagement in São Paulo. 18:38 Ethics committees’ central role in patient safety and informed consent; LATAM’s readiness for decentralized and hybrid trials. 22:14 Emerging local pharma capabilities and cultural factors influencing trial participation, including trust‑based doctor‑patient relationships. 25:15 LATAM as a global talent hub; future accelerators inclu…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/moving-medicine-forward-6832193/episodes/turning-regional-strengths-into-global-impact-the-growth-of-latam-clinical-trials/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/moving-medicine-forward-6832193/turning-regional-strengths-into-global-impact-the-growth-of-latam-clinical-trials.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.